.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Chubb
Harvard Business School
UBS
Citi
US Army
Cipla
Cerilliant
Julphar
Chinese Patent Office

Generated: July 25, 2017

DrugPatentWatch Database Preview

Vitarine Company Profile

« Back to Dashboard

What is the competitive landscape for VITARINE, and what generic and branded alternatives to VITARINE drugs are available?

VITARINE has forty-two approved drugs.



Summary for Applicant: Vitarine

Patents:0
Tradenames:23
Ingredients:23
NDAs:42
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vitarine
PREDNISONE
prednisone
TABLET;ORAL080334-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
PHENDIMETRAZINE TARTRATE
phendimetrazine tartrate
CAPSULE;ORAL086403-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
CEPHALEXIN
cephalexin
FOR SUSPENSION;ORAL062779-001Dec 22, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
PHENDIMETRAZINE TARTRATE
phendimetrazine tartrate
CAPSULE;ORAL085670-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
CORTISONE ACETATE
cortisone acetate
TABLET;ORAL080333-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
US Department of Justice
Federal Trade Commission
McKesson
Queensland Health
Novartis
Citi
Express Scripts
Cipla
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot